Notable Speakers Attending the 2018 Lymphoma & Myeloma Congress

Leading experts in the hematology oncology space will be sharing their insights and presenting cutting-edge research at the 18^th annual Lymphoma & Myeloma (L&M) Congress, October 17-20, 2018, in New York.

The L&M congress now features 4 days of comprehensive learning providing attendees with the opportunity to analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

This year's faculty lineup includes the following notable speakers:

Morton Coleman, MD, FACP

New York-Presbyterian Hospital and Weill Cornell

Richard R. Furman, MD

Weill Cornell Medicine

John P. Leonard, MD

Weill Cornell Medicine, New York

Ruben Niesvizky, MD

New York Presbyterian Hospital-Cornell Medical Center

Gail J. Roboz, MD

Weill Medical College of Cornell University/NewYork-Presbyterian Hospital

John Allan, MD

Weill Cornell Medicine

Kenneth Anderson, MD

Dana-Farber Cancer Institute

David Avigan, MD

Beth Israel Deaconess Medical Center

Jacqueline Barrientos, MD

Hofstra Northwell School of Medicine

Nancy Bartlett, MD

Washington University School of Medicine

Jennifer R. Brown, MD, PhD

Dana-Farber Cancer Institute

John Byrd, MD

The Ohio State University

Jorge Castillo, MD

Dana-Farber Cancer Institute

Leandro Cerchietti, MD

Weill Cornell Medicine

Amy Chadburn, MD

Weill Cornell Medicine

Ajai Chari, MD

Weill Cornell Medicine

Peter Hillmen, MB ChB, PhD

University of Leeds

Hearn Jay Cho, MD, PhD

Mount Sinai Doctors Faculty Practice

Adam Cohen

Abramson Cancer Center, University of Pennsylvania

Jonathon Cohen, MD, MS

Emory Winship Cancer Institute

Pinkal Desai, MD

Weill Cornell Medicine

Andrew Evens, DO, MSc

Rutgers Cancer Institute

Jonathan Friedberg, MD

University of Rochester

Sergio Giralt, MD

Memorial Sloan Kettering Cancer Center

Jeremy Heinerich, PA-C

Weill Cornell Medicine

Giorgio Inghirami, MD

NewYork-Presbyterian Hospital

Caron Jacobson, MD

Dana-Farber Cancer Institute

Rita Jakubowski, NP

Weill Cornell Medicine

Neil Kay, MD

Mayo Clinic

Nadia Kralovic, PA-C

Weill Cornell Medicine

Shaji Kumar, MD

Mayo Clinic

C. Ola Landgren, MD, PhD

Memorial Sloan Kettering Cancer Center

Sangmin Lee, MD

Weill Cornell Medicine

Suzanne Lentzsch, MD, PhD

Columbia University Medical Center

Alexander Lesokhin, MD

Memorial Sloan Kettering Cancer Center

Andrew Lipsky, MD

NewYork-Presbyterian Hospital

Peter Martin, MD

Weill Cornell Medicine

Maria-Victoria Mateos, MD, PhD

University Hospital of Salamanca

Susan McCall, MSN, ANP-BC-AOCNP

Memorial Sloan Kettering Cancer Center

Joseph Mikhael, MD, MEd, FRCPC

International Myeloma Foundation

Samir Parekh, MBBS

Mount Sinai Doctors Faculty Practice

Karen Pekle, NP

Weill Cornell Medicine

Kanti Rai, MD

Hofstra/Northwell School of Medicine

Ellen Ritchie, MD

Weill Cornell Medicine

Cara Rosenbaum, MD

Weill Cornell Medicine

Adriana Rossi, MD

Weill Cornell Medicine

Davide Rossi, MD

Cantonal Hospital Agency

Lisa Roth, MD

Weill Cornell Medicine

Jia Ruan, MD

Weill Cornell Medicine

James Rubenstein, MD, PhD

University of California, San Francisco

Sarah Rutherford, MD

Weill Cornell Medicine

Jesus SanMiguel, MD

Universidad de Navarra

Jennifer Santamala, PharmD, BCOP

NewYork-Presbyterian Hospital

Margaret Shipp, MD

Dana-Farber Cancer Institute

Susan Slager, MD

Mayo Clinic

Sonali Smith, MD

University of Chicago Medicine

Mitchell Smith, MD, PhD

George Washington University Cancer Center

Emilee Thomas, PA-C

Weill Cornell Medicine

Koen vanBesien, MD, PhD

Weill Cornell Medicine

Daniel Verina, NP

Weill Cornell Medicine

Anas Younes, MD

Memorial Sloan Kettering Cancer Center

If you want to find out more about what these experts are going to be discussing, as well as the research that will be presented at L&M 2018, bookmark this page and check back regularly for updates.

You can also stay up to date with the latest news on hematological malignancies by registering to receive Oncology Learning Network e-newsletters that include L&M Congress updates and highlights.

Content (copies of slides, audio and/or video, abstracts) made available from 2018 Lymphoma & Myeloma has been authorized for distribution by the presenters. Presenters are responsible for obtaining all copyright permissions associated with their presentations. Content is provided as an educational resource for participants and is not eligible for continuing education. Should you have questions, please contact Congress organizers at officeofcme@imedex.com.